Clinical Trials Browser

Interventional × Pyloric Stenosis, Hypertrophic × Lenalidomide × Clear all

NCT05328102 2024-04-30

Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (R/R) Diffuse Large-cell B-cell Lymphoma (DLBCL)

Phase 2 Terminated

3 enrolled 6 charts

Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic

NCT00884546 2016-09-30

Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma

Phase 1 Completed

Pyloric Stenosis, Hypertrophic